Aminoretinoic ester
Aminoretinoic ester has been studied in 1 paper since 1988: 1 trial in people. The newest paper, Nov 1, 1988: “Spermidine radioimmunoassay in monitor of precancerous lesions of esophagus”.
1 paper studies it1 findingUpdated
“125.6 +/- 117.2 ng/ml in 64 patients with MEH by Aminoretinoic Ester”
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave aminoretinoic ester to people and measured what changed.
down: Decreases serum spermidine125.6 vs 162.4 ng/ml in controls
Trial64 peopleone year
General population; one year after treatment, compared with placebo controls
Zhonghua zhong liu za zhi [Chinese journal of oncology], Nov 1, 1988
What did studies of Aminoretinoic ester find?
1Studies of Aminoretinoic ester measured 1 outcome; the most studied are serum spermidine (1 study).
Serum spermidine
downin humans1
1 study
Serum spermidine
downin humans1
Aminoretinoic ester decreases serum spermidine in humans (one year after treatment, compared with placebo controls) (125.6 vs 162.4 ng/ml in controls).
“125.6 +/- 117.2 ng/ml in 64 patients with MEH by Aminoretinoic Ester”
Human trialone year after treatment, compared with placebo controlsone yearn = 64
Spermidine radioimmunoassay in monitor of precancerous lesions of esophagus
Zhonghua zhong liu za zhi [Chinese journal of oncology]